• Please log in or register to access this feature.

Does opioid substitution treatment in prisons reduce injecting-related HIV risk behaviours? A systematic review

  1. Sarah Larney

Article first published online: 11 JAN 2010

DOI: 10.1111/j.1360-0443.2009.02826.x

Issue

Addiction

Addiction

Volume 105, Issue 2, pages 216–223, February 2010

Additional Information

How to Cite

Larney, S. (2010), Does opioid substitution treatment in prisons reduce injecting-related HIV risk behaviours? A systematic review. Addiction, 105: 216–223. doi: 10.1111/j.1360-0443.2009.02826.x

Author Information

  1. National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia

*Sarah Larney, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW 2052, Australia. E-mail: s.larney@unsw.edu.au

Publication History

  1. Issue published online: 11 JAN 2010
  2. Article first published online: 11 JAN 2010
  3. Submitted 24 June 2009; initial review completed 20 August 2009; final version accepted 24 September 2009

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (155K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Avril Taylor, Alison Munro, Elizabeth Allen, Karen Dunleavy, Sheila Cameron, Laura Miller, Matthew Hickman, Low incidence of hepatitis C virus among prisoners in Scotland, Addiction, 2013, 108, 6
    Direct Link:
  2. 2
    Stuart A. Kinner, Elizabeth Moore, Matthew J. Spittal, Devon Indig, Opiate substitution treatment to reduce in-prison drug injection: A natural experiment, International Journal of Drug Policy, 2013,

    CrossRef

  3. 3
    Lisa Jakob, Heino Stöver, Tim Pfeiffer-Gerschel, Suchtbezogene Gesundheitsversorgung von Inhaftierten in Deutschland – eine Bestandsaufnahme, SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice, 2013, 59, 1, 39

    CrossRef

  4. 4
    Sarah Larney, Barbara Toson, Lucy Burns, Kate Dolan, Effect of prison-based opioid substitution treatment and post-release retention in treatment on risk of re-incarceration, Addiction, 2012, 107, 2
    Direct Link:
  5. 5
    Dagmar Hedrich, Paula Alves, Michael Farrell, Heino Stöver, Lars Møller, Soraya Mayet, The effectiveness of opioid maintenance treatment in prison settings: a systematic review, Addiction, 2012, 107, 3
    Direct Link:
  6. 6
    Joanne Csete, Karyn Kaplan, Kanna Hayashi, Nadia Fairbairn, Paisan Suwannawong, Ruth Zhang, Evan Wood, Thomas Kerr, Compulsory drug detention center experiences among a community-based sample of injection drug users in Bangkok, Thailand, BMC International Health and Human Rights, 2011, 11, 1, 12

    CrossRef

  7. 7
    Seena Fazel, Jacques Baillargeon, The health of prisoners, The Lancet, 2011, 377, 9769, 956

    CrossRef

  8. 8
    SANDRA A. SPRINGER, Commentary on Larney (2010): A call to action—opioid substitution therapy as a conduit to routine care and primary prevention of HIV transmission among opioid-dependent prisoners, Addiction, 2010, 105, 2
    Direct Link:
  9. 9
    AMY NUNN, NICKOLAS ZALLER, SAMUEL DICKMAN, ANK NIJHAWAN, JOSIAH D. RICH, IMPROVING ACCESS TO OPIATE ADDICTION TREATMENT FOR PRISONERS, Addiction, 2010, 105, 7
    Direct Link:
  10. 10
    Ralf Jürgens, Joanne Csete, Joseph J Amon, Stefan Baral, Chris Beyrer, People who use drugs, HIV, and human rights, The Lancet, 2010, 376, 9739, 475

    CrossRef

  11. 11
    Louisa Degenhardt, Bradley Mathers, Peter Vickerman, Tim Rhodes, Carl Latkin, Matt Hickman, Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed, The Lancet, 2010, 376, 9737, 285

    CrossRef

  12. 12
    M. PATRIZIA CARRIERI, DOMINIQUE REY, LAURENT MICHEL, UNIVERSAL HEPATITIS B VIRUS VACCINATION IN FRENCH PRISONS: BREAKING DOWN THE LAST BARRIERS, Addiction, 2010, 105, 7
    Direct Link:
View Full Article (HTML) Get PDF (155K)